Monday, July 21, 2008

More about the study

Cohen was admitted today to receive the study drug. He will be here until Friday morning as long as everything goes great. He's started the neupogen shot again (the one that enhances the production of white blood cells.) He will also be on the retinoic acid (accutane.) The study drug is called CH 14.18: it's a monoclonal antibody made from human and mouse cells. It specifically targets a substance called GD2 that is expressed on the surface of some cancer cells, including neuroblastoma cells. The study drug can be very painful that's why he'll need to be in the hospital while he's getting it. He'll be on a PCA so hopefully we can manage his pain. I will update this weekend to let you know how it went.

1 comments:

Shauntelle ~ said...

We are still thinking of you. We will pray that all works out and that he won't be too miserable.

With Hope and Love,
Shauntelle and Kaidence

 
Design by Amanda @ BloggerBuster